Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 29
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
GH Research PLC
GHRS
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$21.50
0.79
3.81%
Ult. Agg.: Oct 29, 4:00 PM
Get Report
Panoramica
Notizie
Previsioni utili
Dati finanziari
Sentiment
Confronta
Opzioni
Rapporto azionario
GH Research Analyst Price Targets - Benzinga
GH Research Analyst Price Targets
Wall Street analyst price targets and consensus rating for GH Research (GHRS).
Analyst Ratings News
PRO
Guggenheim Maintains Buy on GH Research, Raises Price Target to $40
Guggenheim analyst Eddie Hickman maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $34 to $40.
Benzinga Newsdesk
PRO
Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40
Cantor Fitzgerald analyst Charles Duncan maintains GH Research (NASDAQ:GHRS) with a Overweight and raises the price target from $35 to $40.
Benzinga Newsdesk
PRO
Needham Maintains Buy on GH Research, Raises Price Target to $39
Needham analyst Ami Fadia maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $32 to $39.
Benzinga Newsdesk
PRO
Wells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44
Wells Fargo analyst Benjamin Burnett initiates coverage on GH Research (NASDAQ:GHRS) with a Overweight rating and announces Price Target of $44.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $65
HC Wainwright & Co. analyst Patrick R. Trucchio maintains GH Research (NASDAQ:GHRS) with a Buy and lowers the price target from $70 to $65.
Benzinga Newsdesk
These Analysts Revise Their Forecasts On GH Research After Q1 Results
GH Research (NASDAQ:GHRS) reported a larger loss than expected in Q1. Analysts lowered price targets, stock fell 3.4%. CEO noted progress in GH001 program.
Avi Kapoor
Crea una watchlist
GRATIS: Segui le azioni e criptovalute con le migliori notifiche di internet
Clicca per iniziare
People Also Watch
Eli Lilly and Co
NYSE:LLY
$1377.34
0.26%
Johnson & Johnson
NYSE:JNJ
$277.11
0.69%
Merck & Co Inc
NYSE:MRK
$147.3
0.66%
Novartis AG
NYSE:NVS
$161.78
0.42%
AstraZeneca PLC
NYSE:AZN
$173.89
-0.29%
Novo Nordisk AS
NYSE:NVO
$38.95
-0.49%
Pfizer Inc
NYSE:PFE
$30.12
0.56%
Bristol-Myers Squibb Co
NYSE:BMY
$61.87
0.78%
Sanofi SA
NASDAQ:SNY
$43.05
-0.19%
GSK PLC
NYSE:GSK
$48.88
0.41%
Mostra tutte le 10 aziende correlate
